-
Product Insights
Serum Albumin – Drugs In Development, 2023
Global Markets Direct’s Serum Albumin provides in depth analysis on Serum Albumin targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Serum Albumin targeted therapeutics development and features...
-
Product Insights
Serum
Serum is a Hydro project located in Sikkim, India. The project is owned by Government of Sikkim. The project is expected to come online in 2028. Empower your strategies with our Serum report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval Analysis for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma)
Overview How likely is it that the drugs in Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Overview Waldenstrom macroglobulinemia, one of the...
-
Product Insights
NewLikelihood of Approval Analysis for Hypersensitivity
Overview How likely is it that the drugs in Hypersensitivity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersensitivity Overview Hypersensitivity reactions (HR) are exaggerated immune responses categorized by Coombs and...
-
Product Insights
NewLikelihood of Approval Analysis for Type I Hypersensitivity
Overview How likely is it that the drugs in Type I Hypersensitivity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Type I Hypersensitivity Overview Type 1 hypersensitivity is a type of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – APBR-3 in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - APBR-3 in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. APBR-3 in Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NM21-1480 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NM21-1480 in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NM21-1480 in Non-Small Cell Lung Cancer Drug Details: NM21-1480 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HPN-328 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HPN-328 in Prostate Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HPN-328 in Prostate Cancer Drug Details: HPN-328 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HPN-328 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HPN-328 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HPN-328 in Colorectal Cancer Drug Details: HPN-328 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – HPN-328 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HPN-328 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HPN-328 in Pancreatic Cancer Drug Details: HPN-328 is under development for the...